Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Keratosis, Actinic × methyl 5-aminolevulinate × Clear all

Phase

Phase 3 4 Phase NA 3 Phase 4 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Basal Cell 1 Keratosis, Actinic 1 Carcinoma, Basal Cell 1

Interventions

LEO 43204 2 methyl 5-aminolevulinate 1 Photochemotherapy 1 Gels 1 Fluorouracil 1 AVX001 1 5-aminolevulinic acid hexyl ester 1 3-ingenyl angelate 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02149342 2016-07-11

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Joint Authority for Päijät-Häme Social and Health Care

Phase 1/2 Completed

14 enrolled 8 charts

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡